Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHANGE Trial: Cilostazol in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06757764Phase 4Recruiting
- Sponsor
- Asan Medical Center
- Start
- Jul 2025
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in ischemic stroke, sponsored by Asan Medical Center. Started Jul 2025; status: recruiting.
02
Drugs
cilostazol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06757764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06757764.